24/7 Market News Snapshot 04 February, 2025 – Quantum Biopharma Ltd. Class B Subordinate Voting Shares (NASDAQ:QNTM)

February 4, 2025

DENVER, Colo., 04 February, 2025 (247marketnews.com) – (NASDAQ:QNTM) are discussed in this article.
Quantum Biopharma Ltd. (NASDAQ:QNTM) is experiencing a remarkable surge in its Class B Subordinate Voting Shares, reaching $6.644 in pre-market trading—a staggering increase of 108.93% from the previous close of $3.180. This significant rise is accompanied by a robust trading volume of 3.02 million shares, reflecting heightened investor interest and confidence in the company’s trajectory.

Contributing to this positive investor sentiment is the announcement of Quantum’s successful completion of a randomized, placebo-controlled study for its innovative dietary supplement, unbuzzd™. The study yielded statistically significant results, illustrating unbuzzd™’s efficacy in accelerating alcohol metabolism. Conducted with participants aged 21 to 43, the findings revealed that unbuzzd™ reduced Blood Alcohol Concentration (BAC) at an average rate over 40% faster than the placebo within just 30 minutes of consumption. Participants also reported notable improvements in alertness and cognitive performance, with a marked decrease in errors following the intake of the supplement.

Moreover, unbuzzd™ demonstrated a capability to stabilize physiological responses during alcohol intoxication, effectively addressing common discomforts such as elevated heart rates and blood pressure fluctuations often associated with drinking. Notably, participants experienced significant relief from hangover symptoms, reporting a considerable reduction in headache severity up to eight hours post-consumption.

Dr. Andrzej Chruscinski, the Vice President of Clinical and Scientific Affairs at Quantum, stated, “The impactful results from our clinical study validate unbuzzd™’s unique advantages for safer social drinking.” CEO Zeeshan Saeed emphasized that unbuzzd™ equips consumers with a scientifically-supported solution, enhancing responsible alcohol consumption while mitigating associated effects.

With a promising product like unbuzzd™, Quantum BioPharma is well-positioned to redefine how consumers approach alcohol intake and recovery, fostering a safer drinking experience in the market.

Related news for (QNTM)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.